Company Profile
- Stock Code
- 068270
- ISIN Code
- KR7068270008
- Currency
- Korean Won (KRW)
- IPO Date
- 2005-07-19

Celltrion, Inc., a biopharmaceutical company, engages in the development, production, and sale of development, production, and sale of medicinal products. It offers biosimilars, including Remsima for rheumatoid arthritis and inflammatory bowel disease; Truxima for non-hodgkin's lymphoma and chronic lymphocytic leukemia; Herzuma for metastatic breast and gast...